Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Insite Vision Inc. -- Ignore unavailable to you. Want to Upgrade?

To: DOLLAR BILL who wrote (973)	9/16/1999 1:05:00 PM
From: Awashonks	Read Replies (1) \| Respond to of 1060

I am expecting the stock to double on the news of a 900 deal. It could do more if the deal is a really good one. I do expect some "sell on the news" reactions after it has run up a bit. The company is working to set up analyst coverage from first tier firms, none of which will come in until the 900 deal is done. They are laying the groundwork now, so once the deal comes through, it will take the least amount of time to get coverage. That will really help. Of course no one really knows what will happen, but from what I've heard from the company, ISV is in a strong negotiating position because there is more than one suitor. Please refer to the Yahoo board for additional info. All the best, Awashonks